NYSE:FIGS

FIGS (FIGS) Stock Price, News & Analysis

$5.04
-0.14 (-2.70%)
(As of 05/3/2024 ET)
Today's Range
$4.99
$5.33
50-Day Range
$4.47
$6.03
52-Week Range
$4.37
$8.84
Volume
3.46 million shs
Average Volume
2.28 million shs
Market Capitalization
$856.35 million
P/E Ratio
45.82
Dividend Yield
N/A
Price Target
$4.94

FIGS MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.67 Rating Score
Upside/​Downside
2.0% Downside
$4.94 Price Target
Short Interest
Bearish
13.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of FIGS in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$285,986 Sold Last Quarter
Proj. Earnings Growth
83.33%
From $0.06 to $0.11 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.81 out of 5 stars

Retail/Wholesale Sector

843rd out of 1,208 stocks

Apparel, Finished Products From Fabrics & Similar Materials Industry

49th out of 90 stocks

FIGS stock logo

About FIGS Stock (NYSE:FIGS)

FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.

FIGS Stock Price History

FIGS Stock News Headlines

FIGS (FIGS) Set to Announce Quarterly Earnings on Thursday
Investors Alert: The Next Big Thing in Weight Loss
UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.
FIGS: Risks Present But Also Upside On Execution
FIGS Is Not Cheap But Is Not Dead Either
Here's Why Figs Stock Plunged Today
Investors Alert: The Next Big Thing in Weight Loss
UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.
FIGS, Inc. 2023 Q4 - Results - Earnings Call Presentation
FIGS: Entering 2024 On Better Footing
FIGS: Decelerating Growth A Cause For Concern
FIGS: Not A Buy, Not A Sell
FIGS: Mixed Outlook Warrants A Cautious Approach
See More Headlines
Receive FIGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FIGS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
5/04/2024
Next Earnings (Confirmed)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Apparel, finished products from fabrics & similar materials
Sub-Industry
N/A
Fax
N/A
Employees
343
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.94
High Stock Price Target
$6.00
Low Stock Price Target
$4.25
Potential Upside/Downside
-2.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
6 Analysts

Profitability

Net Income
$22.64 million
Pretax Margin
7.48%

Debt

Sales & Book Value

Annual Sales
$545.65 million
Cash Flow
$0.14 per share
Book Value
$2.22 per share

Miscellaneous

Free Float
133,550,000
Market Cap
$856.35 million
Optionable
Optionable
Beta
1.41
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

FIGS Stock Analysis - Frequently Asked Questions

Should I buy or sell FIGS stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FIGS in the last twelve months. There are currently 2 sell ratings and 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" FIGS shares.
View FIGS analyst ratings
or view top-rated stocks.

What is FIGS's stock price target for 2024?

6 analysts have issued 1-year price objectives for FIGS's stock. Their FIGS share price targets range from $4.25 to $6.00. On average, they expect the company's share price to reach $4.94 in the next year. This suggests that the stock has a possible downside of 2.0%.
View analysts price targets for FIGS
or view top-rated stocks among Wall Street analysts.

How have FIGS shares performed in 2024?

FIGS's stock was trading at $6.95 at the start of the year. Since then, FIGS stock has decreased by 27.5% and is now trading at $5.04.
View the best growth stocks for 2024 here
.

When is FIGS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our FIGS earnings forecast
.

How can I listen to FIGS's earnings call?

FIGS will be holding an earnings conference call on Thursday, May 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 929-458-6194 with passcode "473290".

How were FIGS's earnings last quarter?

FIGS, Inc. (NYSE:FIGS) posted its quarterly earnings results on Wednesday, February, 28th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.04. The business earned $144.90 million during the quarter, compared to the consensus estimate of $149.09 million. FIGS had a net margin of 4.15% and a trailing twelve-month return on equity of 6.72%. The business's revenue for the quarter was up .0% compared to the same quarter last year. During the same period last year, the firm posted $0.05 EPS.

What ETFs hold FIGS's stock?
When did FIGS IPO?

FIGS (FIGS) raised $394 million in an IPO on Thursday, May 27th 2021. The company issued 22,500,000 shares at $16.00-$19.00 per share. Goldman Sachs, Morgan Stanley, Barclays, Credit Suisse and BofA Securities acted as the underwriters for the IPO.

Who are FIGS's major shareholders?

FIGS's stock is owned by many different retail and institutional investors. Top institutional shareholders include Applied Fundamental Research LLC (1.47%), Applied Fundamental Research LLC (1.47%), Nordea Investment Management AB (0.17%), Sanders Morris Harris LLC (0.08%), Hedges Asset Management LLC (0.04%) and Lineweaver Wealth Advisors LLC (0.01%). Insiders that own company stock include Catherine Eva Spear, Daniella Turenshine, Global Investors Lp Viking, Heather L Hasson, Michael J Soenen, Thomas Tull and Tulco, Llc.
View institutional ownership trends
.

How do I buy shares of FIGS?

Shares of FIGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:FIGS) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners